These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
108 related items for PubMed ID: 29781727
1. sE-cadherin and sVE-cadherin indicate active epithelial/endothelial to mesenchymal transition (EMT and EndoMT) in smokers and COPD: implications for new biomarkers and therapeutics. Eapen MS, Myers S, Lu W, Tanghe C, Sharma P, Sohal SS. Biomarkers; 2018 Nov; 23(7):709-711. PubMed ID: 29781727 [No Abstract] [Full Text] [Related]
10. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome. Villasante A, Pacheco A, Pau E, Ruiz A, Pellicer A, Garcia-Velasco JA. Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038 [Abstract] [Full Text] [Related]
11. sVE-cadherin and sCD146 serum levels in patients with multiple myeloma. Wrobel T, Mazur G, Wolowiec D, Jazwiec B, Sowinska E, Kuliczkowski K. Clin Lab Haematol; 2006 Feb; 28(1):36-9. PubMed ID: 16430458 [Abstract] [Full Text] [Related]
13. Fibroblast-epithelial cell interactions drive epithelial-mesenchymal transition differently in cells from normal and COPD patients. Nishioka M, Venkatesan N, Dessalle K, Mogas A, Kyoh S, Lin TY, Nair P, Baglole CJ, Eidelman DH, Ludwig MS, Hamid Q. Respir Res; 2015 Jun 18; 16(1):72. PubMed ID: 26081431 [Abstract] [Full Text] [Related]
14. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, Yamada M, Suzuki S, Yanai M, Kurosawa S, Yamaya M, Kubo H. Thorax; 2012 Dec 18; 67(12):1067-74. PubMed ID: 22843558 [Abstract] [Full Text] [Related]
16. Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunction. Blaise S, Polena H, Vilgrain I. Vasc Med; 2015 Dec 18; 20(6):557-65. PubMed ID: 26129735 [Abstract] [Full Text] [Related]
17. Epithelial mesenchymal transition in smokers: large versus small airways and relation to airflow obstruction. Mahmood MQ, Sohal SS, Shukla SD, Ward C, Hardikar A, Noor WD, Muller HK, Knight DA, Walters EH. Int J Chron Obstruct Pulmon Dis; 2015 Dec 18; 10():1515-24. PubMed ID: 26346976 [Abstract] [Full Text] [Related]
18. Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail. Wei Z, Shan Z, Shaikh ZA. Toxicol Appl Pharmacol; 2018 Apr 01; 344():46-55. PubMed ID: 29501589 [Abstract] [Full Text] [Related]
19. WNT/β-catenin pathway: A novel therapeutic target for attenuating airway remodelling and EMT in COPD. Eapen MS, Sohal SS. EBioMedicine; 2020 Dec 01; 62():103095. PubMed ID: 33161229 [No Abstract] [Full Text] [Related]
20. Epithelial-mesenchymal Transition (EMT) Markers in Human Pituitary Adenomas Indicate a Clinical Course. Jia W, Zhu J, Martin TA, Jiang A, Sanders AJ, Jiang WG. Anticancer Res; 2015 May 01; 35(5):2635-43. PubMed ID: 25964539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]